BASTROP TX, DARTFORD, UK – 10 October 2019

Caligor Coghlan Pharma Services, a premier, global provider of pharma services, today announced the appointment of Alan Tainty as Global Director of Project Management for the company’s Clinical Supply Services business line.

In this newly formed role, Mr. Tainty will be responsible for ensuring the company’s clients receive service excellence by overseeing the Global Clinical Supply Project Management team. In addition, Mr. Tainty will help develop and drive the strategic direction of the company’s Clinical Supply Services business line.

Mr. Tainty brings over twenty years of experience in Clinical Project Management including two and a half years with Caligor Coghlan Pharma Services. Prior to joining the company, Mr Tainty spent seven years leading a project management team at Mundipharma and eight years leading a project management team at Catalent.

“This is a critical role to help us deliver on our mission to partner with pharmaceutical, biotechnology, and medical device clients to help bring new, life changing medical products and treatments to markets across the world,” said Lisa Rich-Milan, Chief Executive Officer at Caligor Coghlan Pharma Services. “Alan has been an instrumental part of the Clinical Supply Services team. Over the past year, he has worked with our leadership team to help develop our global Clinical Supply Services strategy including the expansion of services being offered at our Dartford, UK facility. We are thrilled with this appointment.”

About Caligor Coghlan Pharma Services
Caligor Coghlan Pharma Services is global provider of pharma services to assist in the development to commercialization of pharmaceutical, biotechnology, and medical device assets. Services include clinical trial design, clinical and commercial packaging and labeling, IMP management and distribution, comparator and ancillary procurement, Clinical Supply Management, Early Access to Medicines services, global Regulatory consulting, commercialized product distribution, and asset acquisition planning. The company operates facilities in Bastrop, TX, USA, and Dartford, UK, and maintains a global network of depots to ensure rapid and timely delivery of therapeutics and supplies to patients and physicians globally.

Media Contact:
Kerry Myers
Vice President of Commercial